19.79

5.77% 1.08

Baxter International Inc (BAX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BAX Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$18.71

Aprire:

$18.67

Volume 24 ore:

15.81M

Relative Volume:

1.76

Capitalizzazione di mercato:

$10.17B

Reddito:

$10.89B

Utile/perdita netta:

$-241.00M

Rapporto P/E:

-74.51

EPS:

-0.2656

Flusso di cassa netto:

$340.00M

1 W Prestazione:

-8.93%

1M Prestazione:

+0.71%

6M Prestazione:

-17.92%

1 anno Prestazione:

-35.37%

Intervallo 1D:

$18.61

$20.13

Intervallo di 1 settimana:

$18.57

$22.41

Portata 52W:

$17.40

$37.74

Baxter International Inc Stock (BAX) Company Profile

Nome

Baxter International Inc

Settore

Healthcare (1111)

Industria

Medical Instruments & Supplies (58)

Telefono

(224) 948-2000

Indirizzo

ONE BAXTER PARKWAY, DEERFIELD, IL

Dipendente

38,000

Cinguettio

@baxter_intl

Prossima data di guadagno

2024-11-08

Ultimi documenti SEC

BAX's Discussions on Twitter

Compare BAX vs ISRG, BDX, ALC, MDLN, RMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BAX Baxter International Inc	19.79	9.62B	10.89B	-241.00M	340.00M	-0.2656
ISRG Intuitive Surgical Inc	485.84	169.97B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	175.89	50.58B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	79.20	38.58B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	44.55	37.11B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	252.55	35.80B	5.40B	1.49B	1.78B	10.12

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-31	Downgrade	Argus	Buy → Hold
2025-08-04	Downgrade	Stifel	Buy → Hold
2025-08-01	Downgrade	Goldman	Buy → Neutral
2025-02-26	Ripresa	Goldman	Buy
2025-02-24	Aggiornamento	Argus	Hold → Buy
2025-02-20	Ripresa	Barclays	Overweight
2024-07-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2024-05-30	Iniziato	Goldman	Neutral
2024-05-10	Downgrade	TD Cowen	Buy → Hold
2023-05-30	Ripresa	Morgan Stanley	Equal-Weight
2023-03-29	Iniziato	UBS	Neutral
2023-01-06	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-01-05	Downgrade	Raymond James	Outperform → Mkt Perform
2023-01-03	Downgrade	BofA Securities	Buy → Neutral
2022-12-19	Downgrade	JP Morgan	Overweight → Neutral
2022-12-15	Downgrade	Deutsche Bank	Buy → Hold
2022-12-12	Downgrade	Citigroup	Buy → Neutral
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Hold
2022-06-24	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-04-04	Downgrade	Goldman	Neutral → Sell
2022-03-02	Ripresa	BofA Securities	Buy
2022-02-18	Reiterato	KeyBanc Capital Markets	Overweight
2022-02-18	Reiterato	Morgan Stanley	Overweight
2022-02-18	Reiterato	Raymond James	Outperform
2022-02-18	Reiterato	Stifel	Buy
2022-02-18	Reiterato	UBS	Neutral
2022-02-18	Reiterato	Wells Fargo	Overweight
2022-02-11	Iniziato	Goldman	Neutral
2022-01-07	Ripresa	Citigroup	Buy
2022-01-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-09-13	Aggiornamento	Cowen	Market Perform → Outperform
2021-09-03	Aggiornamento	Barclays	Equal Weight → Overweight
2021-05-25	Iniziato	Barclays	Equal Weight
2021-01-29	Downgrade	Piper Sandler	Overweight → Neutral
2021-01-06	Downgrade	UBS	Buy → Neutral
2020-12-15	Downgrade	Goldman	Buy → Neutral
2020-10-01	Aggiornamento	Citigroup	Neutral → Buy
2020-09-04	Downgrade	Argus	Buy → Hold
2020-06-24	Iniziato	Oppenheimer	Outperform
2020-03-19	Aggiornamento	Stifel	Hold → Buy
2020-03-18	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2020-03-05	Iniziato	Citigroup	Neutral
2020-02-13	Iniziato	Goldman	Buy
2020-01-02	Aggiornamento	Evercore ISI	In-line → Outperform
2019-12-17	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2019-06-26	Iniziato	KeyBanc Capital Markets	Sector Weight
2019-04-08	Downgrade	Evercore ISI	Outperform → In-line
2019-01-02	Aggiornamento	Citigroup	Neutral → Buy
2019-01-02	Aggiornamento	Morgan Stanley	Underweight → Overweight
2018-11-02	Aggiornamento	Argus	Hold → Buy
2018-10-16	Iniziato	Barclays	Underweight
2018-05-17	Ripresa	Piper Jaffray	Overweight
2018-02-06	Reiterato	Citigroup	Neutral
2018-01-03	Iniziato	Evercore ISI	Outperform
2018-01-03	Aggiornamento	Raymond James	Mkt Perform → Outperform

Mostra tutto

Baxter International Inc Borsa (BAX) Ultime notizie

12:59 PM

The Truth About Baxter International Inc.: Hidden Healthcare Giant or Total Snooze Stock? - AD HOC NEWS

12:59 PM

12:27 PM

Baxter lays off 90 employees from hurricane-hit unit - Medical Buyer

12:27 PM

Feb 13, 2026

Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch

Feb 13, 2026

BAX Q4 Deep Dive: Mixed Segment Performance and Margin Pressures Shape Outlook - Finviz

Feb 13, 2026

Baxter International Inc. (NYSE:BAX) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 13, 2026

Baxter International Inc. (NYSE:BAX) Q4 2025 earnings call transcript - MSN

Feb 13, 2026

Baxter's new CEO mired in damage control before he can address long-term problems - Crain's Chicago Business

Feb 13, 2026

Baxter International Inc. stock underperforms Thursday when compared to competitors - MSN

Feb 13, 2026

Baxter Stock (-16%): Profit Guidance Collapse Triggers De-Risking - Trefis

Feb 13, 2026

Decoding Baxter International Inc (BAX): A Strategic SWOT Insigh - GuruFocus

Feb 13, 2026

Baxter International Is Quietly Going Off – But Is BAX Stock Really Worth Your Money? - AD HOC NEWS

Feb 13, 2026

Feb 12, 2026

Baxter International (BAX) Q4 2025 Sales Exceed Expectations, EPS Falls Short - GuruFocus

Feb 12, 2026

Baxter is the S&P 500’s worst performer today. Earnings were brutal. - MSN

Feb 12, 2026

Baxter International Earnings Call: Growth Meets Margin Squeeze - TipRanks

Feb 12, 2026

BAXTER INTERNATIONAL INC SEC 10-K Report - TradingView

Feb 12, 2026